NCT05563883View on ClinicalTrials.gov

Atrial Fibrillation and Cancer: a Nationwide French Cohort Study

Active, not recruitingOBSERVATIONAL
Enrollment

5,000,000

Participants

Timeline

Start Date

September 22, 2022

Primary Completion Date

January 31, 2030

Study Completion Date

January 31, 2030

Conditions
Atrial FibrillationCancerThromboembolismBleeding
Interventions
OTHER

event occurence

occurence of an event of interest: (AF, cancer, thromboembolism, bleeding, mortality...

Trial Locations (1)

37000

Service de Cardiologie, Centre Hospitalier Universitaire Trousseau, Tours

All Listed Sponsors
collaborator

University Hospital, Tours

OTHER

lead

University Hospital, Caen

OTHER